The Venture Codex Logo

The Venture Codex

Rimonci Capital

WeWork, 17th Floor, Sony Plaza A, No.16 South Guangshun Street, Chaoyang District, Beijing, 100015, China

Overview

Cross-border investment between China and Israel.

Founded

2016

Deals · 12mo

0

Links

WebsiteLinkedIn

Stage focus

Series A
Series B

Geographic focus

France
Israel
United States

Sector focus

—

Investment portfolio

7rounds
NAMEDATESIZE
TECLens
Feb 2025Participated
$9 MSeries A
Laclarée
Feb 2025Participated
$4 MSeed
EyeYon
Mar 2021Participated
$25 MSeries C
EyeControl
Aug 2020Participated
$10 MSeries A
BELKIN Vision
Jul 2020Led
$12 MSeries B
NovaSight
Jul 2020Led
$8 MSeries A
EyeYon
Mar 2017Led
$7 MSeries B
TECLens
Feb 2025Participated
$9 MSeries A
Laclarée
Feb 2025Participated
$4 MSeed
EyeYon
Mar 2021Participated
$25 MSeries C
EyeControl
Aug 2020Participated
$10 MSeries A
BELKIN Vision
Jul 2020Led
$12 MSeries B
NovaSight
Jul 2020Led
$8 MSeries A
EyeYon
Mar 2017Led
$7 MSeries B
7
Items
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Rimonci Capital: 7 funding rounds are recorded in the selected participation categories.All available history.
Rimonci Capital: 7 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Seed01
Series A12
Series B20
Series C+01

Monthly Deal Activity

Rimonci Capital: 7 deals are recorded across 116 months.All available history.
Rimonci Capital: 7 deals are recorded across 116 months. All available history
MonthDeals
Mar '171
Apr '170
May '170
Jun '170
Jul '170
Aug '170
Sep '170
Oct '170
Nov '170
Dec '170
Jan '180
Feb '180
Mar '180
Apr '180
May '180
Jun '180
Jul '180
Aug '180
Sep '180
Oct '180
Nov '180
Dec '180
Jan '190
Feb '190
Mar '190
Apr '190
May '190
Jun '190
Jul '190
Aug '190
Sep '190
Oct '190
Nov '190
Dec '190
Jan '200
Feb '200
Mar '200
Apr '200
May '200
Jun '200
Jul '202
Aug '201
Sep '200
Oct '200
Nov '200
Dec '200
Jan '210
Feb '210
Mar '211
Apr '210
May '210
Jun '210
Jul '210
Aug '210
Sep '210
Oct '210
Nov '210
Dec '210
Jan '220
Feb '220
Mar '220
Apr '220
May '220
Jun '220
Jul '220
Aug '220
Sep '220
Oct '220
Nov '220
Dec '220
Jan '230
Feb '230
Mar '230
Apr '230
May '230
Jun '230
Jul '230
Aug '230
Sep '230
Oct '230
Nov '230
Dec '230
Jan '240
Feb '240
Mar '240
Apr '240
May '240
Jun '240
Jul '240
Aug '240
Sep '240
Oct '240
Nov '240
Dec '240
Jan '250
Feb '252
Mar '250
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '250
Oct '250
Nov '250
Dec '250
Jan '260
Feb '260
Mar '260
Apr '260
May '260
Jun '260
Jul '260
Aug '260
Sep '260
Oct '260

Sector Breakdown

Rimonci Capital: Health & Life Sciences is the largest displayed sector by deal count (6 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Rimonci Capital: Health & Life Sciences is the largest displayed sector by deal count (6 deals). All available history
SectorDeals
Health & Life Sciences6
AI & Machine Learning2
Space & Frontier Tech1
Consumer & Lifestyle1

Deal Size Distribution

Rimonci Capital: 7 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Rimonci Capital: 7 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M1
$5M-$10M3
$10M-$25M2
$25M-$50M1
$50M-$100M0
$100M-$250M0
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

Rimonci Capital: Israel has the largest recorded deal count among the displayed regions (5 deals).All available history.

Top 3 of 3 regions; European countries are grouped as Europe.

Rimonci Capital: Israel has the largest recorded deal count among the displayed regions (5 deals). All available history
RegionDeals
Israel5
United States1
Europe1
Rimonci Capital: 20 co-investors are shown, with CR-CP Life Science Fund sharing 2 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Rimonci Capital: 20 co-investors are shown, with CR-CP Life Science Fund sharing 2 recorded deals. All available history
Co-investorShared deals
CR-CP Life Science Fund2
Pontifax2
Triventures2
Benslie International Fund1
BioLight Life Sciences1
Brighton Park Capital1
C-Mer Eye Care Holdings1
Clive Barret1
Connecticut Innovations1
Diamond BioFund1
Gauss Medical1
Global Health Sciences Fund1
High-Tech Grunderfonds1
Impact First1
Johnson & Johnson Innovation1
Menomadin Foundation1
Santen Ventures1
Sunmed Capital1
UI Investissement1
Yonjin Capital1

Investment Strategy

Rimonci Capital: Led accounts for 43% and participating for 57% of round participation.All available history.
Rimonci Capital: Led accounts for 43% and participating for 57% of round participation. All available history
CategoryDeals (count)Share (%)
Led343%
Participating457%
Rimonci Capital: Single-lead accounts for 33% and co-led for 67% of lead dynamics.All available history.
Rimonci Capital: Single-lead accounts for 33% and co-led for 67% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead133%
Co-led267%

Team

Eddie Wang

COO and Co-Founder

Richel Liu

Founder and CEO